期刊文献+

2型糖尿病患者糖化血红蛋白和C肽水平与肝功能异常关系分析 被引量:3

Relationship between levels of glycosylated hemoglobin and C-peptide and abnormal liver function in patients with type 2 diabetes
暂未订购
导出
摘要 目的探讨2型糖尿病患者血糖控制与肝功能异常的相关性。方法选择该院内分泌科门诊和住院已经确诊的2型糖尿病患者156例,检测其糖化血红蛋白(HbA1c)、空腹血糖(FPG)、餐后2h血糖(2hPG)、空腹C肽(FCP)、餐后2hC肽(2hCP)和肝功能,并对检测结果进行比较及统计学处理,对伴肝功能损害情况进行分析。结果 2型糖尿病患者肝损害发生率37.82%;B组(HbA1c>9%)患者的血糖水平、肝功能异常率显著高于A组(HbA1c≤9%),P<0.01;而B组(HbA1c>9%)C肽水平均明显低于A组(HbA1c≤9%)。结论 HbA1c可反映糖尿病控制好坏与否,较好地控制血糖是改善2型糖尿病患者肝损害的主要措施。 Objective To evaluate the correlation between glycemic control and abnormal liver function in type 2 diabetic patients.Methods 156 cases of patient with definite diagnosis of type 2 diabetes from outpatient and inpatient of Department of Endocrinology were enrolled and detected for glycosylated hemoglobin test(HbA1c),fasting blood glucose(FPG),2 h postprandial blood glucose(2 hPG),fasting C-peptide(FCP),2 h postprandial C-peptide(2 hCP) and liver function.The results and the associated liver damage were compared and statistical analyzed.Results The incidence of liver damage in patients with type 2 diabetes was 37.82 %.Blood glucose level and liver function abnormalities in B group(HbA1c〉9%) were significantly higher than A group(HbA1c≤9%),P〈0.01.C-peptide level in B group(HbA1c〉9%) was significantly lower than that in A group(HbA1c≤9%).Conclusion HbA1c might reflect the diabetes control level.Better glycemic control could be the main measure to improve liver damage in patients with type 2 diabetes.
出处 《国际检验医学杂志》 CAS 2012年第14期1692-1693,1696,共3页 International Journal of Laboratory Medicine
关键词 糖尿病 2型 糖化血红蛋白 C肽 diabetes mellitus,type 2; glycosylated hemoglobin; C-peptide
  • 相关文献

参考文献12

二级参考文献60

共引文献74

同被引文献39

  • 1Vacante M, Malaguarnera M, Motta M, et al. Revision of the ADA - classification of diabetes mellitus type 2 ( DMT2 ) : the importance of maturity onset diabetes ( MOD ), and senile diabetes (DS) [ J ]. Arch Gerontol Geriatr, 2011,53 ( 1 ) : 113 - 119.
  • 2Iwamoto Y, Taniguchi T, Nonaka K, et al. Dose - ranging efficacy of sitagliptin, a dipeptidyl peptidase -4 inhibitor, in Japanese patients with type 2 diabetes mellitus[J]. Endocr J, 2010,57(5) :383 -394.
  • 3Goto A, Takaichi M, Kishimoto M, et al. Body mass index, fasting plasma glucose levels, and C - peptide levels aspredictors of the future insulin use in Japanese type 2 diabetic patients[ J]. Endocr J, 2010,57 (3) :237 -244.
  • 4Chakkera HA, Bodner JK, Heilman RL, et al. Outcomes after simulta- neous pancreas and kidney transplantation and the discriminative ability of the C - peptide measurement pretransplant among type 1 and type 2 diabetes mellitus[J]. Transplant Proc, 2010,42(7) :2650 - 2652.
  • 5Chung JO, Cho DH, Chung DJ, et al. Plasma C - peptide level is in- versely associated with family history of type 2 diabetes in Korean type 2 diabetic patients[J]. Endocr J, 2010,57 (10) :931 - 938.
  • 6Dehghan A,van Hoek M,Sijbrands EJ,et al.High serum uric acid as a novel risk factor for type 2diabetes[J].Diabetes Care,2008,31(2):361-362.
  • 7Ishii H,Kurose I,Kato S.Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress[J].Journal of Gastroenterology and Hepatology,1997,12(9-10):S272-S282.
  • 8Yu ZF,Bruce-Keller AJ,Goodman Y,et al.Uric acid protects neurons against excitotoxic and metabolic insults in cell culture,and aginst focal ischemic brain injury in vivo[J].J Neurosci Res,1998,53(5):613-625.
  • 9付小君.2型糖尿病患者C肽、糖化血红蛋白水平与结直肠腺瘤、腺癌的关系[J].实用临床医学(江西),2009,10(7):38-39. 被引量:4
  • 10王晓来,孙子林.C肽对糖尿病肾脏保护作用的研究进展[J].国际内分泌代谢杂志,2010,30(1):64-66. 被引量:1

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部